5 Best One Dollar Stocks to Buy Now

4. Regulus Therapeutics Inc. (NASDAQ: RGLS)

Stock Price as of July 16: $0.71
Number of Hedge Fund Holders: 6

Regulus Therapeutics Inc. (NASDAQ: RGLS) ranks 4th on the list of 10 best one dollar stocks to buy now. The San Diego-based clinical-stage biopharmaceutical company develops microRNAs therapeutics for cancer, metabolic disease, inflammatory disease, and fibrosis. 

After the first-quarter results, H.C. Wainwright maintained a Buy rating on Regulus Therapeutics Inc. (NASDAQ: RGLS) and lifted the price target to $2 from $1.5, citing promising positive topline data from the first batch of the Phase 1b trial of RGLS4326 for the treatment of patients with autosomal dominant polycystic kidney disease.

The company has a market cap of $53 million. In the first quarter of 2021, Regulus Therapeutics Inc. (NASDAQ: RGLS) had an EPS of -$0.08, beating estimates by $0.01. As of March 31, 2021, Regulus Therapeutics Inc. (NASDAQ: RGLS) had $31.6 million in cash and cash equivalents, up from $31.1 million in the fourth quarter of 2020. 

At the end of the first quarter of 2021, 6 hedge funds in the database of Insider Monkey held stakes worth $14.9 million in Regulus Therapeutics Inc. (NASDAQ: RGLS), up from 4 in the previous quarter worth $11.9 million.